[{"Assets_0_Q2_USD":1315547000.0,"CommonStockSharesOutstanding_0_Q2_shares":51469104.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-283278000.0,"NetIncomeLoss_1_Q2_USD":-168221000.0,"NetIncomeLoss_2_Q2_USD":-331627000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":51257640.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":49882377.0,"StockholdersEquity_0_Q2_USD":1202875000.0,"Ticker":"SAGE","CIK":"1597553","name":"SAGE THERAPEUTICS, INC.","OfficialName":"Sage Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2034401653.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190806"}]